Systemic Lupus Erythematosus (SLE) Clinical Trials in Wuhan, Hubei
5 recruitingWuhan, Hubei, China
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Hangzhou Qihan Biotech Co., Ltd.18 enrolled3 locationsNCT07444307
Recruiting
Early Phase 1
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07339332
Recruiting
Phase 1
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07031713
Recruiting
Not Applicable
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Tongji Hospital6 enrolled1 locationNCT06902844
Recruiting
Early Phase 1
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology34 enrolled1 locationNCT06653556